[go: up one dir, main page]
Skip to main content
Springer Nature Link
Account

Cancer Policy: Pharmaceutical Safety

  • Book
  • © 2019

Overview

Editors:
  1. June M. McKoy

    1. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA

  2. Dennis P. West

    1. Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

  • Describes the latest thoughts and findings relating to drug safety in the cancer domain
  • Covers emerging strategies to identify adverse drug reactions and drug-drug interactions
  • Highlights policies instituted to improve cancer patient safety

Part of the book series: Cancer Treatment and Research (CTAR, volume 171)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook EUR 85.59
Price includes VAT (France)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book EUR 105.49
Price includes VAT (France)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects.

Table of contents (9 chapters)

  1. Front Matter

    Pages i-v
    Download chapter PDF

  2. Impact of Cost on the Safety of Cancer Pharmaceuticals

    • Karen Fitzner, Frederick Oteng-Mensah
    Pages 1-20

  3. Cancer Comorbidity: Implications for Drug Safety

    • Katherine O’Brien, June M. McKoy, Frank Penedo
    Pages 21-35

  4. Pharmacovigilance of Alternative Medications in the Cancer Setting

    • Dustin B. Liebling, Emmanuel Cordova, Gary Deng, June M. McKoy
    Pages 37-45

  5. Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies

    • Brian Chen, John Restaino, Elizabeth Tippett
    Pages 47-59

  6. Biosimilars: Are They Really Safe?

    • June M. McKoy, Frank J. Giles
    Pages 61-73

  7. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety

    • Narissa J. Nonzee, Thanh Ha Luu
    Pages 75-92

  8. Anatomy of Risk Evaluation and Mitigation Strategies (REMS)

    • Kari K. Loeser, June M. McKoy, Glen T. Schumock
    Pages 93-105

  9. Cancer Drug Toxicity: Moving from Patient to Survivor

    • Megan Slocum, Sophie F. Garcia, June M. McKoy
    Pages 107-118

  10. Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos

    • Melissa Simon, Emmanuel Cordova, June M. McKoy
    Pages 119-128
Back to top

Editors and Affiliations

  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA

    June M. McKoy

  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, USA

    Dennis P. West

Accessibility Information

Accessibility information for this book is coming soon. We're working to make it available as quickly as possible. Thank you for your patience.

Bibliographic Information

  • Book Title: Cancer Policy: Pharmaceutical Safety

  • Editors: June M. McKoy, Dennis P. West

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-3-319-43896-2

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2019

  • Hardcover ISBN: 978-3-319-43894-8Published: 16 January 2019

  • eBook ISBN: 978-3-319-43896-2Published: 14 December 2018

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: V, 128

  • Number of Illustrations: 1 b/w illustrations

  • Topics: Oncology, Drug Safety and Pharmacovigilance

Keywords

Publish with us

Policies and ethics

Back to top